CME$263.14
CME Group Inc.
Moat Score
79/100
CME Group has one of the clearest moats in market infrastructure. Its advantages come from liquidity concentration, clearing membership, benchmark contract status, and the operational stickiness of institutional trading workflows. Futures and options on rates, equity indexes, and major commodities naturally gravitate toward the deepest pool, and CME’s clearinghouse reinforces that gravity by reducing counterparty risk and standardizing settlement. The company also benefits from powerful brands in CME, CBOT, NYMEX, and COMEX, plus a broad data and market-access ecosystem. Weaknesses exist at the margins: many products face active competition, and trading volume is cyclical. Even so, CME’s core franchise appears structurally durable and still expanding into new adjacent markets, supporting a wide-moat assessment.
Sign in to see the full analysis
The Strategic Factor Breakdown, Management Quality Assessment, and AI Impact Assessment are available to registered users — it's free.
Financial Score
79/100
CME Group’s standout strength is its exceptional profitability and cash generation, underpinned by a fee-based model supplemented by substantial interest and investment income. Revenue rose from $4.69B in FY2021 to $6.51B in FY2025, while net income increased to $4.07B and TTM reached $4.29B; operating margin expanded to 65.46% and free cash flow margin to 64.45%. Cash flow quality is strong, with operating cash flow reaching $4.28B and free cash flow $4.19B in FY2025, supporting dividends of $3.93B and modest buybacks. The balance sheet is large but stable, though negative tangible book value, $19.79B of intangibles, and $10.52B of goodwill temper the picture. Leverage remains controlled and returns on capital continue to improve, but the high payout ratio limits retention. Overall, CME presents a durable, high-quality financial profile, consistent with its 7.5/10 to 8.5/10 ratings.
Sign in to see the full analysis
The Income Statement, Balance Sheet, Cash Flow, Key Ratios, Forecast, and Fair Value analysis are available to registered users — it's free.
CME’s technical profile is split across timeframes. Near term, the stock looks firm: it is holding above the 20-day and 50-day averages, MACD is positive, and RSI is still comfortably neutral, which supports a modest bullish bias. The bigger-picture trend is less convincing, however, because price remains below the 200-day moving average and the recent Death Cross still frames the intermediate and long-term structure. Bollinger positioning near the upper band suggests upside momentum is present, but volume has not confirmed the move. The most important levels to watch are $272.74 and $274.33 on the upside, while $267.57 and $265.98 are the first support zones that would need to hold to preserve the short-term constructive tone.
Sign in to see the full analysis
See the full short, medium & long-term indicator breakdowns and support/resistance levels — free for registered users.
Frequently asked questions about CME Group Inc.
- Does CME Group Inc. (CME) have an economic moat?
- MoatScan AI rates CME Group Inc. (CME) 79/100 for moat strength, assessed across five sources of competitive advantage: network effects, switching costs, intangible assets, cost advantages and efficient scale. CME Group has one of the clearest moats in market infrastructure.Sign in free to see the Moat Type verdict and the pillar-by-pillar reasoning.
- What is CME Group Inc.'s moat score?
- CME Group Inc. (CME) has a moat score of 79/100. The score is a weighted average of five pillar ratings: network effects, switching costs, intangible assets, cost advantages, and efficient scale. A higher score means the competitive advantages MoatScan AI identifies are wider and more durable.Sign in free to see each pillar rating, the Moat Type verdict and the moat trend.
- How does CME's share price compare with its estimated fair value?
- MoatScan AI estimates CME's intrinsic value with a discounted cash flow (DCF) model and shows how that estimate compares with the market price at the time of analysis. The estimate updates with each new financial analysis and is a research estimate, not a recommendation.Sign in free to see the fair value estimate and how it compares with the price.
- What is CME Group Inc.'s fair value estimate?
- MoatScan AI derives CME Group Inc.'s (CME) fair value per share from a discounted cash flow (DCF) model built on the company's reported financials, analyst growth forecasts, and a discount rate reflecting its cost of capital. The Financial Analysis tab shows the estimate alongside every assumption behind it.Sign in free to see the estimate and the full assumptions behind it.
Other Wide Moat companies
- METAMeta Platforms, Inc.80
- NVDANVIDIA Corporation80
- TXNTexas Instruments Incorporated78
- AMZNAmazon.com Inc.81
- AAPLApple Inc.76
- AVGOBroadcom Inc.76
- BKNGBooking Holdings Inc.76
- CPRTCopart Inc. (DE)76
Disclaimer: The analysis on this page is generated by AI and is provided for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any security. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decisions. MoatScan AI is an educational research tool. It is not licensed or registered with the Securities Commission Malaysia or any other financial regulator, and it holds no positions in, and receives no compensation from, any company analysed.